Growth Metrics

Takeda Pharmaceutical (TKPHF) Change in Account Payables (2018 - 2025)

Historic Change in Account Payables for Takeda Pharmaceutical (TKPHF) over the last 8 years, with Q4 2025 value amounting to $21.4 million.

  • Takeda Pharmaceutical's Change in Account Payables fell 8343.19% to $21.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.4 million, marking a year-over-year increase of 10297.35%. This contributed to the annual value of -$46.7 million for FY2025, which is 3189.55% up from last year.
  • Takeda Pharmaceutical's Change in Account Payables amounted to $21.4 million in Q4 2025, which was down 8343.19% from $112.2 million recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Change in Account Payables ranged from a high of $1.1 billion in Q1 2022 and a low of -$751.0 million during Q2 2022
  • In the last 5 years, Takeda Pharmaceutical's Change in Account Payables had a median value of $12.0 million in 2024 and averaged $31.9 million.
  • Per our database at Business Quant, Takeda Pharmaceutical's Change in Account Payables tumbled by 30233.91% in 2022 and then soared by 435276.79% in 2025.
  • Takeda Pharmaceutical's Change in Account Payables (Quarter) stood at $63.7 million in 2021, then crashed by 185.62% to -$54.6 million in 2022, then soared by 970.94% to $475.4 million in 2023, then crashed by 72.84% to $129.1 million in 2024, then crashed by 83.43% to $21.4 million in 2025.
  • Its Change in Account Payables was $21.4 million in Q4 2025, compared to $112.2 million in Q3 2025 and -$192.0 million in Q2 2025.